The electron-beam welding (EBW) behaviors of pure Mg and the AZ31, AZ61, and AZ91 Mg alloys are examined in this study, in terms of fusion-zone characteristics, grain structures, texture evolution, and joint efficiency. With increasing A1 content, the Mg-based materials were found to be more easily fusion welded. The AZ91 alloy could be welded using a beam power of 2200 W and a weld speed of 16 mm/s, resulting in a weld depth of 29 mm with a fusion-zone aspect ratio of 8.2. The grains inside the fusion zone were nearly equiaxed in shape and ϳ10 m in size, due to the rapid cooling rate. Extended partial melting zones were observed in alloys with high solute contents, such as AZ61 and AZ91. The postweld tensile strength of the Mg alloys could recover back to ϳ80 to 110 pct of the original strength. The texture in the fusion zone was traced by X-ray diffraction (XRD) and electron-backscattered diffraction (EBSD). The grain orientations inside the rapidly solidified electron-beam-welded fusion zones are still rather diversely distributed. The a 1 -, a 2 -, and a 3 -axes of some grains tend to align at 90 or 30 deg with respect to welding direction, and the c-axis tends to align along the plate normal direction. The influence from surface tension on the weld top-surface appearance and weld depth was not pronounced for the current four Mg materials. Instead, differences in the solidus temperatures and thermal conductivity should be the primary factors.

No abstract

No abstract

No abstract

No abstract

Background Capillary non-perfusion is an important characteristic for diabetic retinopathy (DR) indicating microvascular damage and ischemia. Data on the description and treatment outcomes of DR with large area of non-perfusion are lacking to date. We aim to describe the characteristics and treatment outcomes in a series of patients with DR who presented extensively large area of capillary non-perfusion (LACNP). Methods Fundus fluorescein angiograms from medical charts in patients diagnosed with DR between Jan 2017 and Dec 2019 were retrospectively reviewed. Clinical data in eyes with LACNP including imaging and laboratory findings at the first presentation were analyzed. The LACNP was defined as over 70% area of capillary non-perfusion throughout the whole image retina. The mean follow-up duration was 12.4 ± 16.7 months. Follow-up data including extensive pan-retinal photocoagulation and surgical intervention and treatment outcomes were evaluated. Results A total of 43 eyes in 24 patients with LACNP were included, accounting for 3.3% of DR populations in the same period. The overall percentage of non-perfusion area was 79.1 ± 8.1%. All patients received proper control of diabetes and hypertension, and extensive pan-retinal laser photocoagulation. During the follow-up periods, 20 eyes (46.5%) developed severe neovascular complications, of which 15 eyes (34.9%) underwent vitrectomy and/or anti-glaucoma surgeries. Conservative therapies including glycemic control and supplemental laser photocoagulation were conducted in 23 eyes (53.5%) without neovascular complications. In the final follow-up, best corrected visual acuity improved or maintained stable in 19 eyes (44.2%) while deteriorated in 24 eyes (55.8%). Conclusions The presence of LACNP is the hallmark of advanced DR and often indicates a poor visual outcome, although aggressive treatments may slow DR progression and maintain central vision for some time.

The data from this study suggested that sub-tenon's anesthesia could reversibly block visual conduction in rabbit's eyes.

No abstract